TriangleFOR PATIENTS · SOURCE READING
Treatment of Newly Diagnosed Stage IV, Relapsed, and Recurrent Non-Small Cell Lung Cancer
Source: Non-Small Cell Lung Cancer Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: May 16, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
Treatment of newly stage IV, relapsed, and recurrent non-small cell lung cancer may include:
Source links and citations
one or more chemotherapy drugs with or without targeted therapy
Source links and citations
combination chemotherapy followed by more chemotherapy as maintenance therapy to help keep cancer from progressing
Source links and citations
targeted therapy
one or more immunotherapy drugs
Source links and citations
Learn more about these treatments and find a list of chemotherapy, targeted therapy, and immunotherapy drugs for lung cancer in the Treatment Option Overview.
Source links and citations
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice